The U.S. has approved Moderna’s new COVID-19 vaccine, mNexspike, which is a lower-dose option targeting high-risk individuals aged 65 and older, and those aged 12 to 64 with health conditions, reflecting a more cautious approach to vaccine distribution. This decision contrasts with the unrestricted availability of Moderna’s existing vaccine, which is approved for individuals six months and older. The FDA’s approval was based on studies showing mNexspike’s safety and effectiveness, occurring amid changes in CDC recommendations under Health Secretary Robert F. Kennedy Jr. questioning the benefits of COVID-19 vaccines for healthy children.
Full Article
Mysterious deaths of 21 dogs at upstate New York boarding facility under investigation
The Washington County Sheriff's Office is investigating the deaths of 21 dogs found at Anastasia's Acres Dog Boarding Facility in Argyle, New York, with reports suggesting a ventilation issue may have caused suffocation. The facility's owners are cooperating with authorities, and it is currently closed until further notice, while pet owners mourn the loss of their animals. Want More Context? 🔎
Read more